Internal Medicine, Rheumatology · Hyannis, MA
NPI
1427095553
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
700 Attucks Ln, Unit 2a
Hyannis, MA, 02601
Phone (508) 790-2619
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
297 services
Medicare patients, 2024
192
Average age 72
Drug cost, 2024
$2.5M
2,008 prescriptions
Company payments, 2025
$600
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ann Trout was code 99214 (office e&m - established), 77 times for 60 patients. In total Ann Trout billed 297 services in 10 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 77 | 60 | $67.86 | $5,225 |
| 99214 Office E&M - Established | Facility | 66 | 56 | $58.79 | $3,880 |
| 99205 Office E&M - New | Office | 36 | 36 | $128.54 | $4,627 |
| 99215 Office E&M - Established | Facility | 36 | 28 | $104.16 | $3,750 |
| 99215 Office E&M - Established | Office | 34 | 28 | $96.29 | $3,274 |
| 99213 Office E&M - Established | Office | 20 | 17 | $49.93 | $999 |
By year: 2022 $23K for 268 services; 2023 $25K for 318 services; 2024 $23K for 297 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ann Trout prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 250 prescriptions and refills. In total Ann Trout wrote 2,008 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 250 | 592 | 85 | $7,314 |
| Hydroxychloroquine Sulfate Generic | 223 | 571 | 83 | $8,712 |
| Prednisone Generic | 215 | 347 | 84 | $2,289 |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 95 | 95 | 13 | $308K |
| Leflunomide Generic | 84 | 174 | 27 | $2,694 |
| Rinvoq Upadacitinib | 82 | 84 | 15 | $550K |
| Allopurinol Generic | 80 | 217 | 25 | $1,514 |
| Orencia Clickject Abatacept | 78 | 78 | Under 11 | $436K |
| Diclofenac Sodium Generic | 54 | 62 | 34 | $1,280 |
| Colchicine Generic | 53 | 87 | 16 | $2,049 |
| Leucovorin Calcium Generic | 49 | 70 | Under 11 | $929 |
| Gabapentin Generic | 44 | 66 | 14 | $486 |
| Mycophenolate Mofetil Generic | 39 | 78 | Under 11 | $5,993 |
| Humira(Cf) Pen Adalimumab | 36 | 42 | 12 | $300K |
| Alendronate Sodium Generic | 34 | 95 | 12 | $640 |
Brand drugs: - claims; generic drugs: 1,512 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ann Trout $600 ($600 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $143.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 10 | $143 |
| UCB, Inc. UCB.BR | 3 | $120 |
| Amgen Inc. AMGN | 6 | $117 |
| Genzyme Corporation SNY | 2 | $51.75 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $45.62 |
| GlaxoSmithKline, LLC. GSK | 2 | $37.81 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $33.29 |
| Mallinckrodt Hospital Products Inc. | 1 | $21.66 |
| Sobi, Inc SOBI.ST | 1 | $15.21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.